In € millions |
Note |
20091 |
|
2010 |
|
||
|
|
|
|
|
|
||
|
|||||||
Continuing operations |
|
|
|
|
|
||
|
|
13,028 |
|
14,640 |
|||
Cost of sales |
|
|
(7,788) |
|
(8,672) |
||
Gross profit |
|
|
5,240 |
|
5,968 |
||
Selling expenses |
|
(3,086) |
|
(3,341) |
|
||
General and administrative expenses |
|
(1,024) |
|
(1,103) |
|
||
Research and development expenses |
|
(327) |
|
(334) |
|
||
Other operating income/(expenses) |
52 |
|
29 |
|
|||
|
|
|
(4,385) |
|
(4,749) |
||
Operating income |
|
|
855 |
|
1,219 |
||
Financing income |
|
58 |
|
51 |
|||
Financing expenses related to pensions |
|
(171) |
|
(100) |
|||
Other financing expenses |
|
(292) |
|
(278) |
|||
Results from associates and joint ventures |
|
21 |
|
25 |
|||
Profit before tax |
|
|
471 |
|
917 |
||
Income tax |
|
(141) |
|
(170) |
|||
Profit for the period from continuing operations |
|
|
330 |
|
747 |
||
|
|
|
|
|
|
||
Discontinued operations |
|
|
|
|
|
||
Profit for the period from discontinued operations |
|
32 |
|
90 |
|||
Profit for the period |
|
|
362 |
|
837 |
||
|
|
|
|
|
|
||
Attributable to |
|
|
|
|
|
||
Shareholders of the company |
|
|
285 |
|
754 |
||
Non-controlling interests |
|
|
77 |
|
83 |
||
|
|
362 |
|
837 |
|||
|
|
|
|
|
|
||
Earnings per share, in € |
|
|
|
|
|
||
Continuing operations: |
|
|
|
|
|
||
– Basic |
|
1.09 |
|
2.85 |
|||
– Diluted |
|
1.08 |
|
2.83 |
|||
Discontinued operations: |
|
|
|
|
|
||
– Basic |
|
0.14 |
|
0.38 |
|||
– Diluted |
|
0.13 |
|
0.38 |
|||
Total operations: |
|
|
|
|
|
||
– Basic |
|
1.23 |
|
3.23 |
|||
– Diluted |
|
1.21 |
|
3.21 |
Consolidated statement of income
for the year ended December 31